Ustekinumab, a human interleukin 12/23 monoclonal antibody, for psoriatic arthritis: Randomised, double-blind, placebo-controlled, crossover trial (Lancet (2009) 373 (633-640))

A. Gottlieb; A. Menter; A. Mendelsohn

doi:10.1016/S0140-6736(10)62033-8

Ustekinumab, a human interleukin 12/23 monoclonal antibody, for psoriatic arthritis: Randomised, double-blind, placebo-controlled, crossover trial (Lancet (2009) 373 (633-640))

A. Gottlieb
, A. Menter
, A. Mendelsohn

Research output: Contribution to journal › Comment/debate

2 Scopus citations

Original language	English
Pages (from-to)	1542
Number of pages	1
Journal	The Lancet
Volume	376
Issue number	9752
DOIs	https://doi.org/10.1016/S0140-6736(10)62033-8
State	Published - 6 Nov 2010

Access to Document

10.1016/S0140-6736(10)62033-8

Cite this

@article{337612e1f2bf40439df84c01b2db817b,

title = "Ustekinumab, a human interleukin 12/23 monoclonal antibody, for psoriatic arthritis: Randomised, double-blind, placebo-controlled, crossover trial (Lancet (2009) 373 (633-640))",

author = "A. Gottlieb and A. Menter and A. Mendelsohn",

year = "2010",

month = nov,

day = "6",

doi = "10.1016/S0140-6736(10)62033-8",

language = "English",

volume = "376",

pages = "1542",

journal = "The Lancet",

issn = "0140-6736",

publisher = "Elsevier B.V.",

number = "9752",

}

TY - JOUR

T1 - Ustekinumab, a human interleukin 12/23 monoclonal antibody, for psoriatic arthritis

T2 - Randomised, double-blind, placebo-controlled, crossover trial (Lancet (2009) 373 (633-640))

AU - Gottlieb, A.

AU - Menter, A.

AU - Mendelsohn, A.

PY - 2010/11/6

Y1 - 2010/11/6

UR - https://www.scopus.com/pages/publications/78149286841

U2 - 10.1016/S0140-6736(10)62033-8

DO - 10.1016/S0140-6736(10)62033-8

M3 - Comment/debate

AN - SCOPUS:78149286841

SN - 0140-6736

VL - 376

SP - 1542

JO - The Lancet

JF - The Lancet

IS - 9752

ER -